First Page | Document Content | |
---|---|---|
Date: 2013-10-29 14:03:04Clinical research Orphan drug Pharmaceuticals policy Orphan Drug Act Pharmacology European Medicines Agency Rare disease Pharmaceutical drug Alopecia totalis Pharmaceutical sciences Health Drug discovery | Presentazione standard di PowerPointAdd to Reading ListSource URL: www1.wfh.orgDownload Document from Source WebsiteFile Size: 1,15 MBShare Document on Facebook |
COMP Monthly Report fromApril 2015 meetingDocID: 1gtQW - View Document | |
Presentazione standard di PowerPointDocID: 1axXU - View Document | |
PDF DocumentDocID: 17fuW - View Document | |
AlopeciaModel: Empowering Conscious Perception and Experience of Alopecia Areata Introduction I would like to introduce you to AlopeciaModel, a tool designed to empower the alopeciaDocID: 12qDv - View Document | |
Orphan Drugs The term "orphan drug" refers to a product that treats a rare disease affecting fewer than 200,000 Americans. The Orphan Drug Act was signed into law on January 4, 1983. Since the Orphan Drug Act passed, oveDocID: AX71 - View Document |